Fosun Pharmaceutical bought Concert Pharmaceuticals Concert Pharmaceuticals from 1/19/23

User image

Vladimir Petenev

News editor
press@blackterminal.com

Fosun Pharmaceutical bought Concert Pharmaceuticals for $576 million, or $8 per share.

Concert Pharmaceuticals

Review

Source:

{source} pictogram

ir.concertpharma.com

Vladimir Petenev

News editor

Write your comment first

News feed

Yandex has introduced YandexGPT 5

2/25/25 YDEX

Take Charge partner network to grow 2.5 times by the end of 2026

2/25/25 YDEX

Henderson reported for January 2025

2/25/25 HNFG

Ozon opened the first customs and logistics center

2/25/25 OZON

Kamaz modernizes the K5 cab assembly line

2/25/25 KMAZ

Samolet Plus completed 185.9 thousand transactions in 2024

2/25/25 SMLT

VTB's net profit for 2024 increased by 27.6%

2/25/25 VTBR

MGKL launched its own resale platform

2/25/25 MGKL

Moscow Exchange to delist Cian receipts

2/24/25 CIAN

Moscow Exchange to suspend trading in Polyus shares for split

2/24/25 PLZL